Trial Profile
Phase 1 Trial of Lonsurf with Irinotecan and Bevacizumab in Patients with Unresectable Metastatic Colorectal Cancer(mCRC).
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 Jun 2018
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Bevacizumab; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions
- 12 Jun 2018 Status changed from not yet recruiting to recruiting.
- 19 Sep 2015 New trial record